Sfoglia per Autore
Decreased regulatory CD4+CD25+ Treg cells in newly diagnosed type 1 diabetes
2003-01-01 Richiusa, P; Citarrella, R; Mattina, A; Pizzolanti, G; Aluia, R; Ciresi, A; Galluzzo, A; Giordano, C
Systolic flow peak of inferior thyroid arteries in Graves’disease: A predictive parameter for the ophalmopathy development.
2004-01-01 RUSSO L; R CITARRELLA; P RICHIUSA; G BLUNDA; S MERLINO; A CIRESI; A GALLUZZO; G CARUSO; G SELVAGGIO; GIORDANO C
Il c-peptide come marker principale nella storia naturale del Diabete tipo 1: ruolo della funzione b-cellulare pancreatica nelle complicanze
2004-01-01 CIRESI A; CITARRELLA R; RUSSO L; AMATO MC; D'ACQUISTO G; MATTINA A; GALLUZZO A; GIORDANO C
GH-suppression test in acromegaly: comparison between OGTT and chocolate test
2005-01-01 CIRESI A; AMATO MC; MATTINA A; D'ACQUISTO G; MALATO M; GALLUZZO A; GIORDANO C
No effect of GH/IGF-1 excess on adrenal glands in acromegalic patients
2007-01-01 CIRESI A; AMATO MC; RICHIUSA P; LO COCO R; VETRO C; LO COCO A; LO RE F; MATTINA A; D'ACQUISTO G; GALLUZZO A; GIORDANO C
Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes
2007-01-01 Amato, M.; Ciresi, A.; Criscimanna, A.; Allotta, M.; Mattina, A.; Galluzzo, A.; Giordano, C.
Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency
2007-01-01 Ciresi, A.; Amato, M.; Criscimanna, A.; Mattina, A.; Vetro, C.; Galluzzo, A.; D'Acquisto, G.; Giordano, C.
Relative Hypoleptinemia in Poorly Controlled Patients with Type 1 Diabetes
2007-01-01 Amato, MC; Ciresi, A; Richiusa, P; Criscimanna, A; Allotta, L; Mattina, A; Galluzzo, A; Giordano, C
Adrenal morphology and function in acromegalic patients in relation to disease activity.
2009-01-01 Ciresi, A; Amato, MC; Vetro, C; Lo Coco, R; Galluzzo, A; Giordano, C
OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes.
2010-01-01 Ciresi, A.; Amato, M.; MORREALE BUBELLA, D.; MORREALE BUBELLA, R.; Di Giovanna, F.; Carità, S.; Lodato, G.; Galluzzo, A.; Giordano, C.
Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory
2011-01-01 Giordano, C.; Amato, M.; Ciresi, A.; Citarrella, R.; Mantione, L.; Accidenti, M.; Pantò, F.; Guarnotta, V.; Allotta, M.; Criscimanna, A.; Galluzzo, A.
Cornea in acromegalic patients as a possible target of growth hormone action.
2011-01-01 Ciresi, A.; Amato, M.; MORREALE BUBELLA, D.; Lodato, G.; Galluzzo, A.; Giordano, C.
Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy
2011-01-01 Ciresi, A.; Amato, M.; Galluzzo, A.; Giordano, C.
Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study
2012-01-01 Giordano, C.; Ciresi, A.; Amato, M.; Pivonello, R.; Auriemma, R.; Grasso, L.; Galluzzo, A.; Colao, A.
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association?
2012-01-01 Ciresi, A.; Guarnotta, V.; Tomasello, L.; Calo', V.; Galluzzo, A.; Giordano, C.; Russo, A.
Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients.
2012-01-01 Ciresi, A.; Amato, M.; Pizzolanti, G.; Giordano, C.
Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia.
2012-01-01 Cambuli, V.; Galdiero, M.; Mastinu, M.; Pigliaru, F.; Auriemma, R.; Ciresi, A.; Pivonello, R.; Amato, M.; Giordano, C.; Mariotti, S.; Colao, A.; Baroni, M.
Trattamento con GH e metabolismo glucidico
2013-01-01 Ciresi, A.; Giordano, C.
The Metabolic Profile in Active Acromegaly is Gender-Specific.
2013-01-01 Ciresi, A.; Amato, M.; Pivonello, R.; Nazzari, E.; Grasso, L.; Minuto, F.; Ferone, D.; Colao, A.; Giordano, C.
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.
2013-01-01 Ciresi, A.; Amato, M.; Guarnotta, V.; Lo Castro, F.; Giordano, C.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile